StonvexLoading…
StonvexStonvexStonvexCore line items from EG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $4.07B | $17.50B | $13.07B | $8.75B |
Operating Income | $736.00M | $1.89B | $1.33B | $1.06B |
Net Income | $653.00M | $1.59B | $1.15B | $890.00M |
EPS (Diluted) | $16.21 | $37.80 | $27.06 | $20.93 |
Total Assets | $62.34B | $62.51B | $62.24B | $60.52B |
Total Liabilities | $47.05B | $47.05B | $46.86B | $45.50B |
Cash & Equivalents | $1.42B | $1.32B | $1.54B | $1.90B |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 74.50M | 74.40M | 74.40M | 74.40M |